HCM
SRNE

Highlander Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Highlander Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$10 Hold
1,200
– – ﹤0.01% 941
2023
Q4 		$148 Hold
1,200
– – ﹤0.01% 953
2023
Q3 		$0 Buy
+1,200
New – ﹤0.01% 952

Other funds holding SRNE

LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Highlander Capital Management's SRNE Position: Q1 2024 in Review

Highlander Capital Management held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q1 2024 at 1,200 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Highlander Capital Management first reported a position in SRNE in Q3 2023 and has held it in 3 quarters since. The position peaked at $148 in Q4 2023. 7 funds tracked by Wall St. Rank hold SRNE as of Q1 2024.

  • Highlander Capital Management held 1,200 shares of Sorrento Therapeutics, Inc. worth $10 as of Q1 2024.
  • Highlander Capital Management left its Sorrento Therapeutics, Inc. share count unchanged in Q1 2024.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #941 holding.
  • Highlander Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2023 and has held it in 3 quarters since.
  • Highlander Capital Management's Sorrento Therapeutics, Inc. position peaked at $148 in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.